Operating Income (Loss) in USD of CASSAVA SCIENCES INC from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
CASSAVA SCIENCES INC quarterly/annual Operating Income (Loss) history and change rate from Q2 2010 to Q3 2025.
  • CASSAVA SCIENCES INC Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$11.9M, a 61.3% increase year-over-year.
  • CASSAVA SCIENCES INC Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$111M, a 17.4% increase year-over-year.
  • CASSAVA SCIENCES INC annual Operating Income (Loss) for 2024 was -$141M, a 33.5% decline from 2023.
  • CASSAVA SCIENCES INC annual Operating Income (Loss) for 2023 was -$106M, a 32.4% decline from 2022.
  • CASSAVA SCIENCES INC annual Operating Income (Loss) for 2022 was -$80M, a 143% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

CASSAVA SCIENCES INC Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$111M -$11.9M +$18.8M +61.3% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 -$130M -$45.4M +$16M +26.1% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 -$146M -$24.6M -$4.65M -23.3% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 -$141M -$29.5M -$6.7M -29.4% 01 Oct 2024 31 Dec 2024 10-K 03 Mar 2025
Q3 2024 -$135M -$30.6M -$2.74M -9.84% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025
Q2 2024 -$132M -$61.4M -$32.6M -113% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 -$99.4M -$19.9M +$6.58M +24.8% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 -$106M -$22.8M -$1.85M -8.85% 01 Oct 2023 31 Dec 2023 10-K 03 Mar 2025
Q3 2023 -$104M -$27.9M -$6.53M -30.6% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 -$97.6M -$28.8M -$8.86M -44.5% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$88.7M -$26.5M -$8.69M -48.8% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024
Q4 2022 -$80M -$20.9M -$6.49M -45% 01 Oct 2022 31 Dec 2022 10-K 03 Mar 2025
Q3 2022 -$73.5M -$21.3M -$11.6M -119% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023
Q2 2022 -$61.9M -$19.9M -$14.8M -288% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023
Q1 2022 -$47.2M -$17.8M -$14.3M -404% 01 Jan 2022 31 Mar 2022 10-Q 01 May 2023
Q4 2021 -$32.9M -$14.4M -$11.8M -450% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2024
Q3 2021 -$21M -$9.75M -$8.32M -579% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 -$12.7M -$5.14M -$3.98M -342% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q1 2021 -$8.76M -$3.53M -$2.31M -189% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q4 2020 -$6.45M -$2.62M -$1.05M -66.5% 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2023
Q3 2020 -$5.4M -$1.44M -$658K -84.5% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 -$4.74M -$1.16M -$10K -0.87% 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021
Q1 2020 -$4.73M -$1.22M +$229K +15.8% 01 Jan 2020 31 Mar 2020 10-Q 29 Apr 2021
Q4 2019 -$4.96M -$1.58M -$826K -110% 01 Oct 2019 31 Dec 2019 10-K 23 Mar 2021
Q3 2019 -$4.13M -$779K +$505K +39.3% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 -$4.64M -$1.15M +$1.31M +53.1% 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020
Q1 2019 -$5.95M -$1.45M +$716K +33% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020
Q4 2018 -$6.66M -$750K +$1.67M +69% 01 Oct 2018 31 Dec 2018 10-K 26 Mar 2020
Q3 2018 -$8.34M -$1.28M +$1.31M +50.5% 01 Jul 2018 30 Sep 2018 10-Q 29 Oct 2019
Q2 2018 -$9.65M -$2.46M +$1.71M +40.9% 01 Apr 2018 30 Jun 2018 10-Q 26 Jul 2018
Q1 2018 -$11.4M -$2.17M +$597K +21.6% 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019
Q4 2017 -$11.9M -$2.42M +$120K +4.72% 01 Oct 2017 31 Dec 2017 10-K 29 Mar 2019
Q3 2017 -$12.1M -$2.6M +$945K +26.7% 01 Jul 2017 30 Sep 2017 10-Q 30 Oct 2018
Q2 2017 -$13M -$4.17M -$1.12M -36.9% 01 Apr 2017 30 Jun 2017 10-Q 26 Jul 2018
Q1 2017 -$11.9M -$2.76M +$3.07M +52.6% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018
Q4 2016 -$15M -$2.54M +$1.99M +43.9% 01 Oct 2016 31 Dec 2016 10-K 06 Feb 2018
Q3 2016 -$16.9M -$3.54M +$145K +3.93% 01 Jul 2016 30 Sep 2016 10-Q 01 Nov 2017
Q2 2016 -$17.1M -$3.04M +$343K +10.1% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017
Q1 2016 -$17.4M -$5.83M -$3.23M -125% 01 Jan 2016 31 Mar 2016 10-Q 26 Apr 2017
Q4 2015 -$14.2M -$4.53M -$2.37M -109% 01 Oct 2015 31 Dec 2015 10-K 07 Mar 2017
Q3 2015 -$11.8M -$3.69M -$141K -3.98% 01 Jul 2015 30 Sep 2015 10-Q 26 Oct 2016
Q2 2015 -$11.7M -$3.39M -$130K -3.99% 01 Apr 2015 30 Jun 2015 10-Q 19 Jul 2016
Q1 2015 -$11.6M -$2.6M +$869K +25.1% 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016
Q4 2014 -$12.4M -$2.17M -$35.1M -107% 01 Oct 2014 31 Dec 2014 10-K 07 Mar 2017
Q3 2014 $22.6M -$3.55M -$2.77M -357% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015
Q2 2014 $25.4M -$3.26M -$2.94M -921% 01 Apr 2014 30 Jun 2014 10-Q 23 Jul 2015
Q1 2014 $28.3M -$3.46M -$3.02M -682% 01 Jan 2014 31 Mar 2014 10-Q 08 May 2015
Q4 2013 $31.4M $32.9M +$34.7M 01 Oct 2013 31 Dec 2013 10-K 03 Mar 2016
Q3 2013 -$3.38M -$776K +$879K +53.1% 01 Jul 2013 30 Sep 2013 10-Q 05 Nov 2014
Q2 2013 -$4.26M -$319K -$66K -26.1% 01 Apr 2013 30 Jun 2013 10-Q 06 Aug 2014
Q1 2013 -$4.19M -$443K -$295K -199% 01 Jan 2013 31 Mar 2013 10-Q 07 May 2014
Q4 2012 -$3.9M -$1.84M -$1.26M -215% 01 Oct 2012 31 Dec 2012 10-K 18 Feb 2015
Q3 2012 -$2.64M -$1.66M -$632K -61.8% 01 Jul 2012 30 Sep 2012 10-Q 01 Nov 2013
Q2 2012 -$2.01M -$253K +$1.18M +82.3% 01 Apr 2012 30 Jun 2012 10-Q 01 Aug 2013
Q1 2012 -$3.18M -$148K +$331K +69.1% 01 Jan 2012 31 Mar 2012 10-Q 24 Apr 2013
Q4 2011 -$3.51M -$584K 01 Oct 2011 31 Dec 2011 10-K 05 Feb 2014
Q3 2011 -$1.02M +$549K +34.9% 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012
Q2 2011 -$1.43M -$173K -13.8% 01 Apr 2011 30 Jun 2011 10-Q 02 Aug 2012
Q1 2011 -$479K 01 Jan 2011 31 Mar 2011 10-Q 08 May 2012
Q3 2010 -$1.57M 01 Jul 2010 30 Sep 2010 10-Q 03 Nov 2011
Q2 2010 -$1.26M 01 Apr 2010 30 Jun 2010 10-Q 04 Aug 2011

CASSAVA SCIENCES INC Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$141M -$35.5M -33.5% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2025
2023 -$106M -$25.9M -32.4% 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2025
2022 -$80M -$47.2M -143% 01 Jan 2022 31 Dec 2022 10-K 03 Mar 2025
2021 -$32.9M -$26.4M -410% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024
2020 -$6.45M -$1.49M -30% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023
2019 -$4.96M +$1.7M +25.6% 01 Jan 2019 31 Dec 2019 10-K 23 Mar 2021
2018 -$6.66M +$5.29M +44.2% 01 Jan 2018 31 Dec 2018 10-K 26 Mar 2020
2017 -$11.9M +$3.01M +20.1% 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019
2016 -$15M -$755K -5.32% 01 Jan 2016 31 Dec 2016 10-K 06 Feb 2018
2015 -$14.2M -$1.77M -14.2% 01 Jan 2015 31 Dec 2015 10-K 07 Mar 2017
2014 -$12.4M -$43.8M -140% 01 Jan 2014 31 Dec 2014 10-K 07 Mar 2017
2013 $31.4M +$35.3M 01 Jan 2013 31 Dec 2013 10-K 03 Mar 2016
2012 -$3.9M -$383K -10.9% 01 Jan 2012 31 Dec 2012 10-K 18 Feb 2015
2011 -$3.51M +$10.2M +74.4% 01 Jan 2011 31 Dec 2011 10-K 05 Feb 2014
2010 -$13.7M 01 Jan 2010 31 Dec 2010 10-K 08 Feb 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.